Bond Laboratories, a nutritional supplements provider, announced that it improved the terms of its existing line of credit with U.S. Bank. The new agreement increases the company’s borrowing capacity by 50%, from $2 million to $3 million and further reduces the effective rate of interest on the credit line.

“U.S. Bank remains a committed partner in Bond’s continued growth. The newly expanded credit facility is further validation of the company’s strong anticipated future growth prospects,” stated Bond Labs’ CEO, John S. Wilson. “The expanded facility will provide the company with the flexibility to seize current and future growth opportunities both domestically and internationally.”